866-997-4948(US-Canada Toll Free)

Europe Recombinant Protein Drugs Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 115 Pages

Notes:
Sales, means the sales volume of Recombinant Protein Drugs
Revenue, means the sales value of Recombinant Protein Drugs

This report studies sales (consumption) of Recombinant Protein Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Protein Drugs in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Recombinant Protein Drugs in each application, can be divided into
Application 1
Application 2

Table of Contents

Europe Recombinant Protein Drugs Market Report 2017
1 Recombinant Protein Drugs Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs
1.2.1 Type I
1.2.2 Type II
1.3 Application of Recombinant Protein Drugs
1.3.1 Application 1
1.3.2 Application 2
1.4 Recombinant Protein Drugs Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Recombinant Protein Drugs (2012-2022)
1.5.1 Europe Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
1.5.2 Europe Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)

2 Europe Recombinant Protein Drugs by Manufacturers, Type and Application
2.1 Europe Recombinant Protein Drugs Market Competition by Manufacturers
2.1.1 Europe Recombinant Protein Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Recombinant Protein Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Recombinant Protein Drugs (Volume and Value) by Type
2.2.1 Europe Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Europe Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
2.3 Europe Recombinant Protein Drugs (Volume and Value) by Countries
2.3.1 Europe Recombinant Protein Drugs Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Recombinant Protein Drugs Revenue and Market Share by Countries (2012-2017)
2.4 Europe Recombinant Protein Drugs (Volume) by Application

3 Germany Recombinant Protein Drugs (Volume, Value and Sales Price)
3.1 Germany Recombinant Protein Drugs Sales and Value (2012-2017)
3.1.1 Germany Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
3.1.2 Germany Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
3.1.3 Germany Recombinant Protein Drugs Sales Price Trend (2012-2017)
3.2 Germany Recombinant Protein Drugs Sales and Market Share by Manufacturers
3.3 Germany Recombinant Protein Drugs Sales and Market Share by Type
3.4 Germany Recombinant Protein Drugs Sales and Market Share by Application

4 France Recombinant Protein Drugs (Volume, Value and Sales Price)
4.1 France Recombinant Protein Drugs Sales and Value (2012-2017)
4.1.1 France Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
4.1.2 France Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
4.1.4 France Recombinant Protein Drugs Sales Price Trend (2012-2017)
4.2 France Recombinant Protein Drugs Sales and Market Share by Manufacturers
4.3 France Recombinant Protein Drugs Sales and Market Share by Type
4.4 France Recombinant Protein Drugs Sales and Market Share by Application

5 UK Recombinant Protein Drugs (Volume, Value and Sales Price)
5.1 UK Recombinant Protein Drugs Sales and Value (2012-2017)
5.1.1 UK Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
5.1.2 UK Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
5.1.5 UK Recombinant Protein Drugs Sales Price Trend (2012-2017)
5.2 UK Recombinant Protein Drugs Sales and Market Share by Manufacturers
5.3 UK Recombinant Protein Drugs Sales and Market Share by Type
5.4 UK Recombinant Protein Drugs Sales and Market Share by Application

6 Russia Recombinant Protein Drugs (Volume, Value and Sales Price)
6.1 Russia Recombinant Protein Drugs Sales and Value (2012-2017)
6.1.1 Russia Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
6.1.2 Russia Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
6.1.6 Russia Recombinant Protein Drugs Sales Price Trend (2012-2017)
6.2 Russia Recombinant Protein Drugs Sales and Market Share by Manufacturers
6.3 Russia Recombinant Protein Drugs Sales and Market Share by Type
6.4 Russia Recombinant Protein Drugs Sales and Market Share by Application

7 Italy Recombinant Protein Drugs (Volume, Value and Sales Price)
7.1 Italy Recombinant Protein Drugs Sales and Value (2012-2017)
7.1.1 Italy Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
7.1.2 Italy Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
7.1.7 Italy Recombinant Protein Drugs Sales Price Trend (2012-2017)
7.2 Italy Recombinant Protein Drugs Sales and Market Share by Manufacturers
7.3 Italy Recombinant Protein Drugs Sales and Market Share by Type
7.4 Italy Recombinant Protein Drugs Sales and Market Share by Application

8 Spain Recombinant Protein Drugs (Volume, Value and Sales Price)
8.1 Spain Recombinant Protein Drugs Sales and Value (2012-2017)
8.1.1 Spain Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
8.1.2 Spain Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
8.1.8 Spain Recombinant Protein Drugs Sales Price Trend (2012-2017)
8.2 Spain Recombinant Protein Drugs Sales and Market Share by Manufacturers
8.3 Spain Recombinant Protein Drugs Sales and Market Share by Type
8.4 Spain Recombinant Protein Drugs Sales and Market Share by Application

9 Benelux Recombinant Protein Drugs (Volume, Value and Sales Price)
9.1 Benelux Recombinant Protein Drugs Sales and Value (2012-2017)
9.1.1 Benelux Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
9.1.2 Benelux Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Recombinant Protein Drugs Sales Price Trend (2012-2017)
9.2 Benelux Recombinant Protein Drugs Sales and Market Share by Manufacturers
9.3 Benelux Recombinant Protein Drugs Sales and Market Share by Type
9.4 Benelux Recombinant Protein Drugs Sales and Market Share by Application

10 Europe Recombinant Protein Drugs Manufacturers Analysis
10.1 Novo Nordisk
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Recombinant Protein Drugs Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Amgen
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Recombinant Protein Drugs Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Sanofi
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Recombinant Protein Drugs Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Eli Lilly
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Recombinant Protein Drugs Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Merck Serono
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Recombinant Protein Drugs Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Ortho Biotech
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Recombinant Protein Drugs Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Roche
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Recombinant Protein Drugs Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Kyowa Hakko Kirin
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Recombinant Protein Drugs Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Pharmingen
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Recombinant Protein Drugs Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Abcam
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Recombinant Protein Drugs Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 GenSci
10.12 SL PHARM
10.13 Dongbao Pharm
10.14 Ankebio
10.15 NCPC
10.16 Heng Rui

11 Recombinant Protein Drugs Manufacturing Cost Analysis
11.1 Recombinant Protein Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Recombinant Protein Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Recombinant Protein Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Recombinant Protein Drugs Market Forecast (2017-2022)
14.1 Germany Recombinant Protein Drugs Sales Forecast (2017-2022)
14.2 France Recombinant Protein Drugs Sales Forecast (2017-2022)
14.3 UK Recombinant Protein Drugs Sales Forecast (2017-2022)
14.4 Russia Recombinant Protein Drugs Sales Forecast (2017-2022)
14.5 Italy Recombinant Protein Drugs Sales Forecast (2017-2022)
14.6 Spain Recombinant Protein Drugs Sales Forecast (2017-2022)
14.7 Benelux Recombinant Protein Drugs Sales Forecast (2017-2022)
14.8 Europe Recombinant Protein Drugs Sales Forecast by Type (2017-2022)
14.9 Europe Recombinant Protein Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Recombinant Protein Drugs
Table Classification of Recombinant Protein Drugs
Figure Europe Sales Market Share of Recombinant Protein Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Recombinant Protein Drugs
Figure Europe Sales Market Share of Recombinant Protein Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure France Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure UK Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Russia Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Italy Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Spain Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Benelux Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
Figure Europe Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Table Europe Recombinant Protein Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Recombinant Protein Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Protein Drugs Sales Share by Manufacturers
Figure 2016 Recombinant Protein Drugs Sales Share by Manufacturers
Table Europe Recombinant Protein Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Recombinant Protein Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Recombinant Protein Drugs Revenue Share by Manufacturers
Table 2016 Europe Recombinant Protein Drugs Revenue Share by Manufacturers
Table Europe Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
Table Europe Recombinant Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure Europe Recombinant Protein Drugs Sales Growth Rate by Type (2012-2017)
Table Europe Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
Table Europe Recombinant Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure Europe Recombinant Protein Drugs Revenue Growth Rate by Type (2012-2017)
Table Europe Recombinant Protein Drugs Sales and Market Share by Countries (2012-2017)
Table Europe Recombinant Protein Drugs Sales Share by Countries (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Countries (2012-2017)
Table Europe Recombinant Protein Drugs Revenue and Market Share by Countries (2012-2017)
Table Europe Recombinant Protein Drugs Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Countries (2012-2017)
Table Europe Recombinant Protein Drugs Sales and Market Share by Application (2012-2017)
Table Europe Recombinant Protein Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Application (2012-2017)
Figure Germany Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Germany Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Germany Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Germany Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table Germany Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table Germany Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table Germany Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Figure France Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure France Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure France Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table France Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table France Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table France Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table France Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table France Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table France Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Figure UK Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure UK Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure UK Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table UK Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table UK Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table UK Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table UK Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table UK Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Figure Russia Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Russia Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Russia Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Russia Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table Russia Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table Russia Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table Russia Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Figure Italy Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Italy Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Italy Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Italy Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table Italy Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table Italy Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table Italy Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Figure Spain Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Spain Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Spain Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Spain Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table Spain Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table Spain Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table Spain Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Figure Benelux Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Benelux Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Benelux Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Benelux Recombinant Protein Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Recombinant Protein Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Recombinant Protein Drugs Sales by Type (2015 and 2016)
Table Benelux Recombinant Protein Drugs Market Share by Type (2015 and 2016)
Table Benelux Recombinant Protein Drugs Sales by Application (2015 and 2016)
Table Benelux Recombinant Protein Drugs Market Share by Application (2015 and 2016)
Table Recombinant Protein Drugs Basic Information List
Table Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Serono Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Ortho Biotech Basic Information List
Table Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ortho Biotech Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Pharmingen Basic Information List
Table Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pharmingen Recombinant Protein Drugs Sales Market Share (2012-2017)
Table Abcam Basic Information List
Table Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abcam Recombinant Protein Drugs Sales Market Share (2012-2017)
Table GenSci Basic Information List
Table SL PHARM Basic Information List
Table Dongbao Pharm Basic Information List
Table Ankebio Basic Information List
Table NCPC Basic Information List
Table Heng Rui Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure Germany Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Germany Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure France Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure France Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Europe Recombinant Protein Drugs Sales Forecast by Type (2017-2022)
Table Europe Recombinant Protein Drugs Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *